Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Cash from Investing Activities: 2021-2024

Historic Cash from Investing Activities for biote (BTMD) over the last 4 years, with FY2024 value amounting to -$18.8 million.

  • biote's Cash from Investing Activities rose 6504.56% to -$690000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year increase of 7859.96%. This contributed to the annual value of -$18.8 million for FY2024, which is 59288.61% down from last year.
  • biote's Cash from Investing Activities amounted to -$18.8 million in FY2024, which was down 59288.61% from -$2.7 million recorded in FY2023.
  • biote's 5-year Cash from Investing Activities high stood at -$1.8 million for FY2022, and its period low was -$18.8 million during FY2024.
  • Its 4-year average for Cash from Investing Activities is -$6.8 million, with a median of -$3.3 million in 2021.
  • Per our database at Business Quant, biote's Cash from Investing Activities surged by 5172.05% in 2022 and then crashed by 59288.61% in 2024.
  • biote's Cash from Investing Activities (Annual) stood at -$3.8 million in 2021, then surged by 51.72% to -$1.8 million in 2022, then crashed by 47.61% to -$2.7 million in 2023, then tumbled by 592.89% to -$18.8 million in 2024.
  • Its last three reported values are -$18.8 million in FY2024, -$2.7 million for FY2023, and -$1.8 million during FY2022.